Dr Alison Chiu Left in theatre, implanting STAAR SURGICAL EVO VIVA
Dr Alison Chiu performed the first implantation of the ICL Viva by Staar Surgical across Australia and New Zealand, a breakthrough innovation in ICL surgery that corrects both myopia (short-sightedness) and presbyopia (age-related near vision decline) for patients over 40.
This milestone further cements Dr Chiu’s reputation as one of Australia’s most experienced ICL surgeons, having performed ICL surgery in Sydney since 2012. Over more than a decade, she has helped hundreds of patients achieve natural, high-definition vision through this advanced lens-based technology.
The announcement was made months after the procedures took place, as Dr Chiu intentionally allowed time to thoroughly follow up on patient outcomes and ensure the results stand the test of time beyond the immediate post-operative period.
Collaboration and Support
The success of this pioneering procedure reflects years of industry support and professional collaboration. Device Technologies and Staar Surgical have been instrumental in bringing this game-changing technology to Australia, while peer guidance from colleagues such as Dr Scott Barnes (for surgical insight) and Dr Bobby Ang (for invaluable mentorship) has played a key role in its introduction.
Why the ICL Viva Is Revolutionary
The EVO ICL Viva represents a new generation of implantable collamer lenses (ICL) designed to provide sharp, full-range vision, without altering the cornea. This is particularly important for patients who may wish to consider broad options for other procedures that are common and often inevitable later in life, such as cataract surgery.
Unlike traditional laser eye surgery, which reshapes the cornea, ICL surgery preserves the natural structure of the eye. This means greater flexibility, reversibility, and optical quality, especially in patients with high myopia, thinner corneas, or early presbyopia.
While laser vision correction remains an excellent option for many, outcomes depend heavily on the skill and experience of your surgeon. Dr Chiu’s extensive experience with both laser and lens-based refractive surgery allows her to provide truly individualised recommendations.
Looking Ahead
Dr Alison Chiu is confident that the EVO ICL Viva will transform how presbyopia is treated across Australia. This innovative advancement in ICL surgery offers an elegant, lens-based solution for patients seeking spectacle independence beyond their 40s, delivering exceptional clarity, comfort, and long-term visual stability. As 2025 draws to a close, Dr Chiu remains the most experienced ICL Viva surgeon in Australia and New Zealand, with only two other highly experienced surgeons currently accredited to perform this breakthrough procedure. Having performed ICL surgery in Sydney since 2012, Dr Chiu continues to lead the way in ICL surgery in Australia.
Other alternatives for presbyopia correction include Presbyond™ which can be discussed in detail during your consultation.
For more information or to book an assessment, please contact us at Pure Sight Eye Surgeons Sydney’s trusted centre for ICL surgery, laser eye surgery, and advanced refractive procedures.
